Troxerutin
Belcaro G, Cesarone MR, Bavera P, Ricci A, et al.
HR (Venoruton1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in chronic venous disease and microangiopathy: an independent prospective, controlled, randomized trial.
Cesarone MR. et al
HR, 0-(beta-hydroxyethyl)-rutosides; (Venoruton): rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: a prospective, controlled study.
Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM.
A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin.
Petruzzellis V, Troccoli T, Candiani C, Guarisco R, et al.
Oxerutins (Venoruton): efficacy in chronic venous insufficiency--a double-blind, randomized, controlled study.